openPR Logo
Press release

Radiopharmaceuticals Market : How the Business Will Grow in 2026? Prominent Players : Lantheus Medical Imaging Inc., Cardinal Health , Norgine B.V., Curium , Advanced Accelerator Applications (Novartis AG), Bracco Diagnostic Inc. , Jubilant Life Sciences

04-28-2020 09:32 PM CET | Health & Medicine

Press release from: Fortune Business Insights

Radiopharmaceuticals Market

Radiopharmaceuticals Market

The global radiopharmaceuticals market size is projected to reach USD 9.54 billion by 2026. According to a report published by Fortune Business Insights, titled "Radiopharmaceuticals Market Size, Share & Industry Analysis, By Type (PET Radiopharmaceuticals, SPECT Radiopharmaceuticals), By Application (Neurology, Cardiology, Oncology, and Others), By End User (Hospitals & Clinics, Diagnostic Centres, and Others) and Regional Forecast, 2019-2026," the market was valued at USD 4.86 billion in 2018. Driven by increasing number of successful clinical trials, the market will exhibit a CAGR of 9.0% from 2019-2026.

Request a Sample Copy of the Research Report:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nuclear-medicine-radiopharmaceuticals-market-101812

The report covers :
o Global radiopharmaceuticals market trends, with detailed analysis on consumer trends & manufacturer trends.
o Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
o Key areas of investments identifying market opportunities and challenges in forecast time frame.
o Competitive analysis of the industry players along with the overview on strategic management.
o Comprehensive company profiles of the major industry players.

An Overview of the Impact of COVID-19 on this Market :
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.

Click here to get the short-term and long-term impact of COVID-19 on this [Market].
Please visit : https://www.fortunebusinessinsights.com/industry-reports/nuclear-medicine-radiopharmaceuticals-market-101812

Leading Players operating in the Radiopharmaceuticals Market are :

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
o Lantheus Medical Imaging, Inc.
o Cardinal Health
o Norgine B.V.
o Curium
o Advanced Accelerator Applications (Novartis AG)
o Bracco Diagnostic Inc.
o Jubilant Life Sciences Limited
o GE Healthcare (General Electric Company)

Driven by Increasing Number of Product Launches, Market to Expand at a High Rate
The increasing number of product launches has offered a wider scope for growth. The presence of several pipeline drugs will open up a potential for the growth of the market in the coming years. The increased investment has massively helped the development of these pipeline drugs. Increased emphasis on R&D of pipeline drugs has enabled the possibilities to explore the untapped potential that is carried by radiopharmaceuticals. In 2018, Norgine B.V. announced the launch of Lymphoseek, a radiopharmaceutical designed for oncological procedures. The report highlights new products, similar to Lymphoseek and gauges the impact of these products on the market.

North America to Witness Highest Growth; Growing Adoption of Nuclear Imaging to Aid Growth
The report segments the market on the basis of regional demographics into Latin America, North America, Europe, Asia Pacific, and the Middle East and Africa. Among these regions, North America will emerge dominant in the coming years. The advancements in nuclear imaging has contributed to the growth of the market in North America. Increased awareness regarding the adverse effects of cancer and other serious diseases will create several growth opportunities for the companies operating in the regional market of North America.

Have Any Query? Ask Our Experts :
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/nuclear-medicine-radiopharmaceuticals-market-101812

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges

Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Radiopharmaceuticals Market : How the Business Will Grow in 2026? Prominent Players : Lantheus Medical Imaging Inc., Cardinal Health , Norgine B.V., Curium , Advanced Accelerator Applications (Novartis AG), Bracco Diagnostic Inc. , Jubilant Life Sciences here

News-ID: 2028213 • Views:

More Releases from Fortune Business Insights

Future of Renewable Energy Market Insights: Growth Drivers, and Regional Developments
Future of Renewable Energy Market Insights: Growth Drivers, and Regional Develop …
Global Renewable Energy Market Overview The global renewable energy market size was valued at USD 954 billion in 2023. The market is projected to grow from USD 1,020.94 billion in 2024 to USD 1,574.17 billion by 2032, exhibiting a CAGR of 5.56% during the forecast period. Asia Pacific dominated the renewable energy market with a market share of 67.76% in 2023. The Renewable energy market in the U.S. is projected to
DC Drives Market Overview: Opportunities, Growth Drivers, and Key Applications
DC Drives Market Overview: Opportunities, Growth Drivers, and Key Applications
Market Overview The global DC drives market size was valued at USD 4.34 billion in 2018 and is projected to reach USD 9.23 billion by 2032, exhibiting a CAGR of 5.59% during the forecast period of 2019-2032. Asia Pacific dominated the global market with a share of 28.8% in 2018. The DC drives market in the U.S. is projected to grow significantly, reaching an estimated value of USD 1.59 billion by
Humanoid Robots Market: An In-depth B2B Analysis of Size, Share, and Future Growth
Humanoid Robots Market: An In-depth B2B Analysis of Size, Share, and Future Grow …
Brief Market Overview: The global humanoid robots market is rapidly transitioning from a nascent field into a major growth sector, with its value escalating from USD 2.43 billion in 2023 to a projected USD 66.0 billion by 2032, demonstrating a remarkable CAGR of 45.5%. These complex machines, which merge mechanical, electrical, and software engineering, are moving beyond research labs into real-world applications across industrial, service, and household sectors. This explosive growth
Methanol Market Poised for Remarkable Growth, set to Reach USD 46.32 billion by 2032 with a CAGR of 4.5%.
Methanol Market Poised for Remarkable Growth, set to Reach USD 46.32 billion by …
The global methanol market size was valued at USD 31.26 billion in 2023. It is projected to grow from USD 32.70 billion in 2024 to USD 46.32 billion by 2032, exhibiting a CAGR of 4.5% during the forecast period. The global methanol market size is set to gain traction from the urgent need to lower environmental pollution caused by the surging usage of heavy fuels, such as diesel and gasoline. Pollution

All 5 Releases


More Releases for Radiopharmaceuticals

Radiopharmaceuticals Market Size, Share | Forecast - 2033
The new report published by The Business Research Company, titled Radiopharmaceuticals Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. As per the report, the radiopharmaceuticals market size has grown steadily in recent years. It will grow from $6.46 billion in 2023 to
Radiopharmaceuticals Market - Harnessing the Power of Radiopharmaceuticals for P …
Newark, New Castle, USA: The "Radiopharmaceuticals Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Radiopharmaceuticals Market: https://www.growthplusreports.com/report/radiopharmaceuticals-market/7842 This latest report researches the industry structure, sales, revenue, price and
Nuclear Medicine/Radiopharmaceuticals Market Growing by Convenience of Radiophar …
Nuclear Medicine/Radiopharmaceuticals Market Outlook 2022-2029 The Nuclear Medicine/Radiopharmaceuticals Market research offers complete knowledge and information on the market's flowing landscape, what is now available on the market, upcoming trends, market expectations, the competitive environment, and methods that may be used to outperform competitors. Market Analysis and Size The Nuclear Medicine/Radiopharmaceuticals Market is currently valued at US$ 10.16 Billion and is projected to register 9.90% CAGR through 2029. Gets a Sample Copy of the Nuclear
Global Radiopharmaceuticals Market Global Radiopharmaceuticals Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Global Radiopharmaceutical Market Overview 1.1 Current Market Scenario 1.2 Diagnostic & Therapeutic Radiopharmaceuticals 1.3 Global Radiopharmaceticals Clinical Pipeline Overview 2. Global Radiopharmaceuticals Market Dynamics 3. Radioisotopes Used in Radiopharmaceuticals 4. EMA Guidelines for Radiopharmaceuticals 4.1 Physico-Chemical, Biological or Microbiological Tests of Medicinal Products 4.2 Toxicological & Pharmacological Tests 4.3 Clinical Documentation 4.4 Radiation
Nuclear Medicine/Radiopharmaceuticals Market
Radiopharmaceuticals are unique medicinal formulations that contain radioisotopes and are used in clinical applications for diagnosis and therapy. The facilities and procedures for production, use, and storage of radiopharmaceuticals are subject to license approval either by national or regional authorities such as Nuclear Regulatory Commission (NRC) of U.S, Atomic Energy Commission (AEC) of U.S., or Atomic Energy Regulatory Board (AERB) of India. Licensing includes compliance regarding pharmaceutical preparations and use
Global Radiopharmaceuticals Market Insight
Radioisotopes are radioactive isotopes having an unstable balance of atomic nucleus. Radioisotopes are produced either by using nuclear research reactor or by using cyclotron. These isotopes emit energy in the form of alpha, beta or gamma when changed to a stable nature. The gamma rays, thus emitted are used in Nuclear medicine, specifically in medical diagnostics. In this field, the radiation is used to provide diagnostic information about a